Terpene-Strengthened Ginkgo biloba Extract as a Platelet-Activating Factor Antagonist |
Quan, Zhe-Jiu
(College of Pharmacy, Yeungnam University)
Moon, Tae-Chul (College of Pharmacy, Yeungnam University) Yang, Ju-Hye (College of Pharmacy, Yeungnam University) Chang, Hyeun-Wook (College of Pharmacy, Yeungnam University) Park, Young-Hyun (College of Natural Sciences, Soonchunhyang University) Kim, Young-Ha (Research Center, Yuyu Inc.) Lee, Kyung-Hee (Research Center, Yuyu Inc.) Chi, Yeon-Sook (College of Pharmacy, Kangwon National University) Lim, Hyun (College of Pharmacy, Kangwon National University) Kim, Hyoung-Chun (College of Pharmacy, Kangwon National University) Kim, Hyun-Pyo (College of Pharmacy, Kangwon National University) |
1 | Chi, Y. S., Cheon, B. S. and Kim, H. P. (2001). Effect of wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase and the induction of inducible nitric oxide synthase in lipopolysaccharide-treated RAW 264.7 cells. Biochem. Pharmacol. 61, 1195-1203 DOI ScienceOn |
2 | DeFeudis, F. V. (1991). Ginkgo biloba extract (Egb761): pharma-cological activities and clinical applications. Elsevier, Paris |
3 | Hanahan, D. J. (1987). Platelet activating factor: A biologically active phosphoglyceride. Ann. Rev. Biochem. 55, 483-509 DOI ScienceOn |
4 | Koltai, M., Hosford, D. and Braquet, P. G. (1996). Platelet-acti-vating factor and its antagonists in allergic and inflammatory disorders. Clin. Allergy Immunol. 8, 463-489 |
5 | Myers, A. K., Nakanishi, T. and Ramwell, P. (1988). Antagonism of PAF-induced death in mice. Prostaglandins 35, 447-458 DOI ScienceOn |
6 | Akiba, S., Murata, K., Kitatani, K. and Sato, T. (2000). Involvement of lipoxygenase pathway in docosapentaenoic acidinduced inhibition of platelet aggregation. Biol. Pharm. Bull. 23, 1293-1297 DOI ScienceOn |
7 | Bourgain, R. H., Andries, R., Esanu, A. and Braquet, P. (1992). PAF-aceter induced arterial thrombosis and the effect of specific antagonists. Adv. Exp. Med. Biol. 316, 427-440 |
8 | Terashita, Z., Kawamura, M., Takatani, M., Tsushima, S., Imura, Y. and Nishikawa, K. (1992). Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. J. Pharmacol. Exp. Ther. 260, 748-755 |
9 | Prescott, S. M., Zimmerman, G. A. and McIntyre, T. M. (1991). Platelet-activating factor. J. Biol. Chem., 17381-17384 |
10 | Redl, H., Vogl, C., Schiesser, A., Paul, E., Thurnher, M., Bahrami, S. and Schlag, G. (1990). Effect of the PAF antagonist BN 52021 in ovine endotoxin shock. J. Lipid Mediat. 2 Suppl, S195-S201 |
11 | Tesch, H. and Konig, W. (1979). Origin and biological role of lipid mediators during inflammation. Immun Infekt. 7, 157-164 |
12 | Valone, F. H., Coles, E., Reinhold, V. R. and Goetzl, E. J. (1982). Specific binding of phospholipid platelet-activating factor by human platelets. J. Immunol. 129, 1637-1641 |
13 | Cheung, F., Siow, Y. L. and O, K. (2001). Inhibition by ginkgolides and bilobalides of the production of nitric oxide in macrophages (THP-1) but not in endothelial cells (HUVEC). Biochem. Pharmacol. 61, 503-510 DOI ScienceOn |